Cafepharma Today

June 2 2025 - Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Sanofi expands rare immunology portfolio with Blueprint buyout
Moderna's next-gen COVID shot gets FDA backing with some limitations
BioNTech flips its cancer bispecific to BMS for a big profit
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Top Drug Stocks
Investopedia
Thursday, June 30, 2011 - 7:45am
tags:
Abbott Laboratories, Allergan, Novartis, Pfizer, PowerShares
Eli Lilly Plans 10 Drugs in Final-Stage Trials by End of 2011
Bloomberg
Thursday, June 30, 2011 - 7:42am
tags:
Eli Lilly, pipelines, R&D
Peregrine Pharma's Secret Weapon
Minyanville
Wednesday, June 29, 2011 - 10:46pm
tags:
Peregrine Pharmaceuticals
Is Affymetrix a Cash King?
Motley Fool
Wednesday, June 29, 2011 - 10:45pm
tags:
Affymetrix
Health care reform law passes first appeals test
Bizjournals.com
Wednesday, June 29, 2011 - 7:47pm
tags:
healthcare reform
Federal panel says government should revoke cancer drug Avastin's approval for breast cancer
Yahoo/AP
Wednesday, June 29, 2011 - 7:46pm
tags:
Avastin, advisory panels, breast cancer, FDA, Roche
Novartis Afinitor Backed in EU
Yahoo/Zacks.com
Wednesday, June 29, 2011 - 7:45pm
tags:
Novartis, Afinitor, Europe, ONYX Pharmaceuticals, Pfizer, brain tumors
Icahn sues Forest for info on Solomon's woes
Fierce Pharma
Wednesday, June 29, 2011 - 10:48am
tags:
Forest Labs, Carl Icahn
Biotechs are looking at a new normal
Boston Globe, MA
Wednesday, June 29, 2011 - 10:27am
tags:
biotech
Biotech Data Mining Comes Up Empty
TheStreet.com
Wednesday, June 29, 2011 - 10:26am
tags:
data mining, Cel-Sci, Apricus Biosciences, Osiris, Transdel, Agenus, Introgen, Cell Therapeutics
Human Genome Sciences’ Watkins elected BIO chair
Bizjournals.com
Wednesday, June 29, 2011 - 10:23am
tags:
BIO, Human Genome Sciences, Thomas Watkins, Pharma CEOs
Newron, Merck Serono conclude patient recruitment in Phase III MOTION study
Pharmaceutical Business Review
Wednesday, June 29, 2011 - 7:30am
tags:
Newron Pharma, Merck Serono, Parkinson's Disease
Medivir: terms of herpes-drug venture are reset
Marketwatch
Wednesday, June 29, 2011 - 6:57am
tags:
herpes, Medivir, Xerese, Meda
Are Dendreon Executives Properly Incentivized?
Seeking Alpha
Wednesday, June 29, 2011 - 6:55am
tags:
Dendreon, executive pay
Merck Says Submits Application for MS Treatment Rebif in Europe
Bloomberg
Wednesday, June 29, 2011 - 6:54am
tags:
Merck, Rebif, MS, Europe, multiple sclerosis
Acorda Pushes Sales of MS Drug
Minyanville
Wednesday, June 29, 2011 - 12:07am
tags:
Acorda Therapeutics, MS, multiple sclerosis, AMPYRA
Biogen Idec Has It All Among Biotech Firms
Seeking Alpha
Wednesday, June 29, 2011 - 12:06am
tags:
Biogen Idec
Study points to possible aspirin link with Astra heart drug
Reuters
Tuesday, June 28, 2011 - 11:38pm
tags:
AstraZeneca, Brilinta, aspirin
Hi-Tech Pharmacal: Bright Future in Generic Drugs
Seeking Alpha
Tuesday, June 28, 2011 - 11:36pm
tags:
Hi Tech Pharmacal, generics
New Data on Abbott Kidney Drug Candidate
Yahoo/Zacks.com
Tuesday, June 28, 2011 - 11:35pm
tags:
Abbott Laboratories, Shire, Sanofi, bardoxolone methyl, Reata, kidney disease

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.